3,4-dihydroxyphenylacetaldehyde has been researched along with trifluoperazine in 1 studies
Studies (3,4-dihydroxyphenylacetaldehyde) | Trials (3,4-dihydroxyphenylacetaldehyde) | Recent Studies (post-2010) (3,4-dihydroxyphenylacetaldehyde) | Studies (trifluoperazine) | Trials (trifluoperazine) | Recent Studies (post-2010) (trifluoperazine) |
---|---|---|---|---|---|
99 | 0 | 50 | 3,696 | 157 | 198 |
Protein | Taxonomy | 3,4-dihydroxyphenylacetaldehyde (IC50) | trifluoperazine (IC50) |
---|---|---|---|
Genome polyprotein | 0.7 | ||
Ubiquitin carboxyl-terminal hydrolase 1 | Homo sapiens (human) | 8 | |
Bile salt export pump | Homo sapiens (human) | 10 | |
Lysozyme C-1 | Rattus norvegicus (Norway rat) | 9 | |
Beta-glucuronidase | Rattus norvegicus (Norway rat) | 7.8 | |
ATP-dependent translocase ABCB1 | Homo sapiens (human) | 6.75 | |
Angiotensin-converting enzyme | Oryctolagus cuniculus (rabbit) | 6.226 | |
Alpha-1B adrenergic receptor | Rattus norvegicus (Norway rat) | 0.35 | |
Alpha-1D adrenergic receptor | Rattus norvegicus (Norway rat) | 0.35 | |
Pleiotropic ABC efflux transporter of multiple drugs | Saccharomyces cerevisiae S288C | 1.4 | |
Alpha-1A adrenergic receptor | Rattus norvegicus (Norway rat) | 0.35 | |
D(2) dopamine receptor | Rattus norvegicus (Norway rat) | 0.016 | |
Potassium voltage-gated channel subfamily H member 2 | Homo sapiens (human) | 6.226 | |
Nuclear receptor subfamily 3 group C member 3 | Bos taurus (cattle) | 6.226 | |
WD repeat-containing protein 48 | Homo sapiens (human) | 8 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Brown, AM; Burke, WJ; Conway, AD; Jain, JC; Kristal, BS; Li, SW; Ulluci, PA | 1 |
1 other study(ies) available for 3,4-dihydroxyphenylacetaldehyde and trifluoperazine
Article | Year |
---|---|
Selective dopaminergic vulnerability: 3,4-dihydroxyphenylacetaldehyde targets mitochondria.
Topics: 3,4-Dihydroxyphenylacetic Acid; 4-Aminobenzoic Acid; Aminobenzoates; Animals; Aristolochic Acids; Cell Death; Cell Differentiation; Cyclosporine; Dopamine; Dopamine Antagonists; Enzyme Inhibitors; Ion Channels; Male; Membrane Proteins; Mitochondria; Mitochondrial Membrane Transport Proteins; Mitochondrial Permeability Transition Pore; Nerve Growth Factor; para-Aminobenzoates; Parkinson Disease; PC12 Cells; Phenanthrenes; Rats; Rats, Inbred F344; Respiration; Rotenone; Trifluoperazine; Uncoupling Agents | 2001 |